Boston, MA, September 6th, Sapphiros announced today that Mike Musgnug has joined the company as EVP Strategy for Sapphiros and CEO of GrapheneDX, a Sapphiros Group Company. In this role, Mike will lead strategy development and business development for Sapphiros in addition to leading the GrapheneDX organization.
Prior to joining Sapphiros, Mr. Musgnug served as Chief Revenue Officer at Discovery Life Sciences, where he was responsible for driving top line growth via organic and inorganic means. Previously, Musgnug served as Vice President and General Manager of the Biotechnology Business Unit at Beckman Coulter Life Sciences, a Danaher company. In this role, he was responsible for four product lines totalling in excess of $1 billion. Previously, he held commercial roles of increasing responsibility at Cepheid and Alere. He also served on the board of TechLab. Mr. Musgnug holds a bachelor’s degree in biology a master’s degree in business administration from Marist College and a master’s degrees in biological sciences from University of Massachusetts Lowell.
Mark Gladwell, COO, Sapphiros commented, “we are excited to have someone of Mike’s caliber join the team. His two decades of executive leadership and management experience in diagnostics and his track record in delivering innovation, commercial growth strategies and value creation will continue to enable Sapphiros to bring transformative diagnostics to the world to enable our vision of Knowing Now Moves Us™.”
Mr. Musgnug commented, “I am delighted to join the talented team at GrapheneDx to help bring this powerful innovation to people’s homes across the world. Additionally, I look forward to partnering with the impressive team at Sapphiros to drive a winning strategy that will transform consumer diagnostics.”
Sapphiros is a privately held Consumer Diagnostic portfolio company, backed by global private equity firm KKR and Neoenta. We believe that “Knowing Now Moves Us™”, with solutions that provide real-time definitive results; at Sapphiros we work together to help global communities act on these important insights and move forward with confidence.